Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
NEW HAVEN, Conn. & SAN DIEGO--(BUSINESS WIRE)--Mar 2, 2026-- Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Candid Therapeutics, Inc. ("Candid"), a global clinical-stage biotechnology company advancing a leading portfolio of T …